CytoMed Therapeutics
GDTC
#10692
Rank
NZ$20.23 M
Marketcap
NZ$1.71
Share price
12.50%
Change (1 day)
-44.96%
Change (1 year)

Market capitalization of CytoMed Therapeutics (GDTC)

Market cap: NZ$20.23 Million

As of July 2026 CytoMed Therapeutics has a market cap of NZ$20.23 Million. This makes CytoMed Therapeutics the world's 10692th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytoMed Therapeutics from 2023 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.23 M-34.72%
2025NZ$30.99 M-47.58%
2024NZ$59.13 M-33.8%
2023NZ$89.33 M

End of Day market cap according to different sources

On Jul 25th, 2026 the market cap of CytoMed Therapeutics was reported to be:

NZ$20.22 Million
by Nasdaq info icon info icon
NZ$20.23 Million
by CompaniesMarketCap info icon info icon